Genetic Microdevices
We have developed a vastly disruptive technology that analyses proteins and DNA with ultra-high performance, addressing a $10bn market.
- Stage Prototype Ready
- Industry Biotechnology
- Location Richmond, GB-ENG, United Kingdom
- Currency USD
- Founded January 2006
- Employees 5
- Website genetic-microdevices.co.uk
Company Summary
Pharamaceutical companies face a tremendeus challenge to invest in new drugs, when the efficiency of R&D is very poor. There is a dire need for new generation analytical technologies that increase the efficiency of drug development. GMD addresses these needs by providing an ultra-potent, cost-effective technology based on a disposable plastic chip. Our customers are pharmaceutical and diagnostic companies, health care and research institututions.
Team
-
Dimitrios SiderisCEO
Dimitrios Sideris is the Inventor & CEO. Dimitrios has 12 years experience in commercializing
cutting edge technology. He has a PhD in particle physics from Imperial College.Career highlights:
• 2000: Head of Technology for an Imperial College London Spinout, DeltaDot, who currently
have products in the market. Award for Most Innovative and Data Intensive Technology in
the Supercomputing conference in Baltimore.
• 2005-date: Raised $2M -
Alan EdwardsChairman
Alan was C.E.O of Credent Vascular Technologies Ltd., formed after a successful £10 million Management Buy-Out from Cardiotech International Inc. Credent was sold in 2004. He is Chairman of Asep Healthcare Ltd., a profitable Imperial College spin-out company; Chairman, of Dialog Devices Ltd; a University of Loughborough Spin-out and an advisor to Ferlin Medical Ltd., Scubacraft and Digital Art.
-
Andreas ManzScientific Board
Andreas Manz is one of the pioneers in microchip technology used for chemical applications. He was involved in the development of high speed analyzers based on capillary electrophoresis, liquid chromatography and flow injection analysis. These analyzers are based on the microfabrication know-how originally developed for microelectronics. He conducted most of his early research with his group at Ciba-Geigy Ltd. in Basel, Switzerland, then at Imper
Advisors
-
Clark HoltLawyerUnconfirmedFarringdon & CoAccountantUnconfirmed
Previous Investors
-
Vasilis Exarchou, Barry May, Andrew May, Giorgos Kyritsis, Mishaal Almashan, Konstantina PanagiotouUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.